Search

Your search keyword '"Legislation, Drug trends"' showing total 438 results

Search Constraints

Start Over You searched for: Descriptor "Legislation, Drug trends" Remove constraint Descriptor: "Legislation, Drug trends" Language english Remove constraint Language: english
438 results on '"Legislation, Drug trends"'

Search Results

1. Canada's cannabis legalization and police-reported cannabis-related criminal incidents among youth, 2015-2021.

2. Abortion-pill challenge provokes doubt from US Supreme Court.

3. United States marijuana legalization and opioid mortality trends before and during the first year of the COVID-19 pandemic.

4. County-Level Recreational Marijuana Policies and Local Policy Changes in Colorado and Washington State (2012-2019).

5. Public health impacts to date of the legalisation of medical and recreational cannabis use in the USA.

6. Methamphetamine exposures reported to United States poison control centers, 2000-2019.

7. Looking back from 2020, how cannabis use and related behaviours changed in Canada.

8. Psychedelics: Old drugs, new trips.

9. Insulin at 100: time for action on costs.

10. Regulatory approval for COVID-19 across the globe.

11. The legalization of cannabinoid products and standardizing cannabis-drug development in the United States: a brief report
.

12. Regulating Medicines in a Globalized World With Increased Recognition and Reliance Among Regulators: A National Academies Report.

13. Facing the option for the legalisation of cannabis use and supply in New Zealand: An overview of relevant evidence, concepts and considerations.

14. The evolution of addiction treatment and harm reduction programs in Iran: a chaotic response or a synergistic diversity?

15. Pharmacology and legal status of cannabidiol.

16. Surveillance from the high ground: sentinel surveillance of injuries and poisonings associated with cannabis.

17. Retrospective Policy Analysis of Tobacco Prevention and Control in Ethiopia.

18. Adolescent treatment admissions for marijuana following recreational legalization in Colorado and Washington.

19. Legal requirements and recommendations to prescribe naloxone.

20. Using MyDispense to simulate validation of controlled substance prescriptions in a pharmacy law course.

21. FDA Approval and Regulation of Pharmaceuticals, 1983-2018.

22. Drug Legalization and Decriminalization Beliefs Among Substance-using and Nonusing Individuals.

23. Association between cannabis laws and opioid prescriptions among privately insured adults in the US.

24. Impact of Medical Marijuana Legalization on Opioid Use, Chronic Opioid Use, and High-risk Opioid Use.

25. Does liberalisation of cannabis policy influence levels of use in adolescents and young adults? A systematic review and meta-analysis.

26. Regulatory Trends in Drug Development in Asia Pacific.

28. Phage Therapy Regulation: From Night to Dawn.

31. Generic Drugs in the United States: Policies to Address Pricing and Competition.

32. Recreational marijuana legalization and prescription opioids received by Medicaid enrollees.

33. Greater risk for frequent marijuana use and problems among young adult marijuana users with a medical marijuana card.

34. Enhancing Pharmacovigilance Capabilities in the EU Regulatory Network: The SCOPE Joint Action.

35. Mandatory minimum sentencing policies and cocaine use in the U.S., 1985-2013.

36. Using a mock board of pharmacy disciplinary hearing to teach concepts related to administrative law, addiction, empathy, and professionalism.

37. What does the ecological and epidemiological evidence indicate about the potential for cannabinoids to reduce opioid use and harms? A comprehensive review.

38. A Minister of Addictions for Canada.

39. Marijuana Use in the Era of Changing Cannabis Laws: What Are the Risks? Who is Most at Risk?

40. Motor vehicle crash fatalaties and undercompensated care associated with legalization of marijuana.

41. Decriminalization of drug use.

42. Planting the seed for marijuana use: Changes in exposure to medical marijuana advertising and subsequent adolescent marijuana use, cognitions, and consequences over seven years.

44. Recent Regulatory Trends in Pharmaceutical Manufacturing and their Impact on the Industry.

46. Addressing Pharmaceutical Injuries: The US Landscape.

47. The three betrayals of the medical cannabis growing activist: From multiple victimhood to reconstruction, redemption and activism.

48. Examining the relationship between medical cannabis laws and cardiovascular deaths in the US.

49. A "not-for-profit" regulatory model for legal recreational cannabis: Insights from the regulation of gaming machine gambling in New Zealand.

50. Affordability Challenges to Value-Based Pricing: Mass Diseases, Orphan Diseases, and Cures.

Catalog

Books, media, physical & digital resources